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Preface 
Eleven years ago the Netherlands Heart Foundation (NHF) took up the 
initiative to start its ambitious Molecular Cardiology Program (MCP).  Considering the 
importance of the application of molecular technologies in cardiovascular research, 
the NHF initiated this program to give an incentive to basic science in the field of 
heart failure and atherosclerosis.  The principal objective was to compete with 
international research on a level of excelence, and to introduce molecular biology 
techniques in a clinical context, thus bridging the exciting gap between clinical and 
basic science. 
In 1994, the first two research programs regarding atherosclerosis were 
launched in Leiden, under supervision of prof. dr. Th.J.C. van Berkel, and in 
Amsterdam, directed by prof. dr. H. Pannekoek.   Atherosclerosis research in Leiden 
was effectively run at the division of Biopharmaceutics by dr. E.A.L. Biessen, at TNO-
PG by dr. P. Quax and at the division of Antropogenetics by Dr. J.A.P. van Dijk.  
Initialy, the main focus was to develop gene therapeutic techniques for 
atherosclerosis and restenosis to complement current pharmacotherapy based on for 
instance the very successful cholesterol lowering statins.  W hile TNO-PG continued 
its research in the development of strategies to prevent and treat restenosis, the 
division of Biopharmaceutics gradualy, particularly after 1997, shifted its focus from 
liver directed drug targeting to therapeutic target finding in the process of plaque 
rupture, the most common cause for obstructive thrombosis and acute ischemic 
events.  W ithin this theme not only the molecular processes involved in plaque 
rupture are being studied, but also imaging techniques for vulnerable atherosclerotic 
plaques are being developed.  
The generous NHS funding initiated a vast expansion of atherosclerosis 
research within the division of Biopharmaceutics which covers many aspects of this 
disease, both pathophysiologicaly as therapeuticaly, from the perspective of basic 
science.  This thesis reports the progress that has been made in mapping the 
pathophysiology of plaque rupture with respect to extracelular matrix modulation.  
Several other PhD students and Postdocs, financed by other grants, are currently 
studying other aspects of the vulnerable plaque, such as apoptosis and inflammation, 
and are developing new molecular research techniques. 
Recently, the jump to the clinic has been made and several clinical studies 
regarding end stage atherosclerosis are presently being conducted in cooperation 
with the Leiden University Medical Centre (dr. Jukema), the University Medical 
Centre Utrecht (dr. Pasterkamp, dr. Prakken), Oosterschelde Hospital in Goes (dr. 
Liem) and the Haaglanden Medical Centre in The Hague (dr. Veldhuizen, dr. De 
Groot).  The objective of these new projects is not only the elucidation of the 
molecular processes that may eventualy lead to acute ischemic events and 
restenosis, but also the identification of diagnostic and prognostic markers in patients 
with myocardial infarction and the discovery of therapeutic targets for acute ischemic 
events.  Observations in humans wil be further elaborated in animal models of 
atherosclerosis, thus contributing to our understanding of vulnerable plaque 
pathobiology, to therapeutic target finding and to individual cardiovascular risk 
stratification.  
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In order to translate these findings from basic science towards applicable 
medicine, it must be noted that ongoing cooperation between basic scientists and 
physicians in conjunction with technological development is of utmost importance. 
This thesis is one of many in the Molecular Cardiology Program to make a 
contribution to a better mutual understanding of both basic and clinical research 
perspectives and a tighter translational cooperation. However, building bridges is not 
done overnight and it will take the effort of many to establish a solidly founded 
integrative platform for atherosclerosis research in the Netherlands. 
Ramon de Nooijer 
Leiden, 31 August 2005 
